Skip to main content
logo
Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.9049
-0.0146 (-1.59%)
At close: Sep 4, 2026, 4:00 PM EDT
0.9175
+0.0126 (1.39%)
After-hours: Sep 4, 2026, 7:59 PM EDT

Nautilus Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
115246211374225643
Market Cap Growth
42.68%16.76%-43.55%66.44%-65.09%-
Enterprise Value
59142102226-4299
Last Close Price
0.901.951.682.991.805.18

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.881.571.011.410.711.77
P/TBV Ratio
0.881.571.011.410.711.77

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.210.190.150.130.100.08
Net Debt / Equity Ratio
-0.43-0.47-0.48-0.52-0.49-0.87
Net Debt / EBITDA Ratio
0.921.131.251.872.476.38
Net Debt / FCF Ratio
1.081.411.602.563.207.61
Quick Ratio
9.7313.0017.0219.0127.1659.49
Current Ratio
10.1413.3317.4019.3927.5760.09
Return on Equity (ROE)
-36.21%-32.27%-29.86%-21.95%-17.07%-22.75%
Return on Assets (ROA)
-20.83%-19.26%-18.57%-14.52%-10.62%-13.06%
Return on Capital Employed (ROCE)
-40.50%-36.50%-34.70%-25.70%-18.50%-12.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-49.08%-23.96%-33.55%-17.04%-25.80%-7.82%
FCF Yield
-45.04%-21.10%-29.40%-14.49%-21.44%-6.45%
Buyback Yield / Dilution
-0.57%-0.66%-0.41%-0.27%-47.51%-190.36%
SEC Filings: 10-K · 10-Q